Amendments for SB21-175
Senate Journal, March 18
After consideration on the merits, the Committee recommends that SB21-175 be amended
as follows, and as so amended, be referred to the Committee on Appropriations with
favorable recommendation.
Amend printed bill, page 8, line 2, strike "10-16-1307 (5)." and substitute
"10-16-1307 (6).".
Page 9, strike lines 7 and 8 and substitute "EACH HAVE AN ADVANCED DEGREE
AND EXPERIENCE OR EXPERTISE IN HEALTH-CARE ECONOMICS OR CLINICAL
MEDICINE.".
Page 9, lines 17 through 19, strike "EACH MEMBER SERVES AT THE PLEASURE
OF THE GOVERNOR AND MAY BE REMOVED FROM THE BOARD BY THE
GOVERNOR." and substitute "THE GOVERNOR MAY REMOVE ANY APPOINTED
MEMBER OF THE BOARD FOR MALFEASANCE IN OFFICE, FOR FAILURE TO
REGULARLY ATTEND MEETINGS, OR FOR ANY CAUSE THAT RENDERS THE
MEMBER INCAPABLE OR UNFIT TO DISCHARGE THE DUTIES OF THE MEMBER'S
OFFICE, AND ANY SUCH REMOVAL IS NOT SUBJECT TO REVIEW.".
Page 9, line 22, after "QUORUM." add "THE CONCURRENCE OF A MAJORITY OF
THE BOARD IN ANY MATTER WITHIN ITS POWERS AND DUTIES IS REQUIRED FOR
ANY DETERMINATION MADE BY THE BOARD.".
Page 10, strike lines 23 through 27.
Renumber succeeding subsection accordingly.
Page 11, line 4, strike "(5)" and substitute "(4)".
Page 11, line 19, strike "(1)(g)." and substitute "(1)(h).".
Page 12, strike lines 13 through 20 and substitute:
"(6) (a) THE DIVISION, ON BEHALF OF THE BOARD, MAY SEEK, ACCEPT,
AND EXPEND GIFTS, GRANTS, AND DONATIONS FROM PRIVATE OR PUBLIC
SOURCES FOR THE PURPOSES OF THIS PART 13, AND ANY SUCH GIFTS, GRANTS,
AND DONATIONS ARE CONTINUOUSLY APPROPRIATED TO THE DEPARTMENT OF
REGULATORY AGENCIES; EXCEPT THAT THE DIVISION SHALL NOT ACCEPT ANY
GIFT, GRANT, OR DONATION THAT CREATES A CONFLICT OF INTEREST OR THE
APPEARANCE OF ANY CONFLICT OF INTEREST FOR ANY BOARD MEMBER.".
Strike "AND" and substitute "OR" on: Page 15, lines 7 and 27.
Page 19, after line 25 insert:
"(f) THE IMPACT ON SAFETY NET PROVIDERS IF THE PRESCRIPTION DRUG
IS AVAILABLE THROUGH SECTION 340B OF THE FEDERAL "PUBLIC HEALTH
SERVICE ACT", PUB.L. 78-410;".
Reletter succeeding paragraphs accordingly.
Page 21, line 21, strike "CONSUMERS." and substitute "CONSUMERS; EXCEPT
THAT THE BOARD MAY NOT ESTABLISH AN UPPER PAYMENT LIMIT FOR MORE
THAN TWELVE PRESCRIPTION DRUGS IN EACH CALENDAR YEAR FOR THREE
YEARS BEGINNING APRIL 1, 2022.".
Page 22, after line 8 insert:
"(3) THE METHODOLOGY DETERMINED BY THE BOARD PURSUANT TO
SUBSECTION (2) OF THIS SECTION SHALL NOT CONSIDER RESEARCH OR METHODS
THAT EMPLOY A DOLLARS-PER-QUALITY ADJUSTED LIFE YEAR, OR SIMILAR
MEASURE, THAT DISCOUNTS THE VALUE OF A LIFE BECAUSE OF AN INDIVIDUAL'S
DISABILITY OR AGE.".
Renumber succeeding subsections accordingly.
Page 24, line 16, strike "PROFESSIONALS;" and substitute "PROFESSIONALS WITH
PRESCRIBING AUTHORITY;".
Page 24, line 26, after "WHO" insert "HAVE EXPERIENCE SERVING UNDERSERVED
COMMUNITIES AND".
Page 24, line 27, after "WEALTH," insert "DISABILITY, AGE, GENDER IDENTITY,".
Page 28, after line 2 insert:
"(5) NOTWITHSTANDING ANY PROVISION OF THIS PART 13 TO THE
CONTRARY, AS USED IN THIS SECTION, "PERSON" DOES NOT INCLUDE AN
INDIVIDUAL WHO ACQUIRES A PRESCRIPTION DRUG FOR THE INDIVIDUAL'S OWN
USE OR FOR A FAMILY MEMBER'S USE.".
Page 28, line 4, after "required" insert "- rules".
Page 28, after line 14 insert:
"(2) THE BOARD SHALL PROMULGATE RULES TO NOTIFY CONSUMERS OF
THE INTENT OF ANY MANUFACTURER TO WITHDRAW A PRESCRIPTION DRUG
FROM SALE OR DISTRIBUTION WITHIN THE STATE, AS DESCRIBED IN SUBSECTION
(1) OF THIS SECTION.".
Renumber succeeding subsection accordingly.
Page 29, after line 19 insert:
"(d) THE IMPACT OF ANY UPPER PAYMENT LIMITS ESTABLISHED BY THE
BOARD PURSUANT TO SECTION 10-16-1307 ON HEALTH-CARE PROVIDERS AND
PHARMACIES;".
Reletter succeeding paragraphs accordingly.
Health &
Human
Services
Senate Journal, April 30
After consideration on the merits, the Committee recommends that SB21-175 be amended
as follows, and as so amended, be referred to the Committee of the Whole with favorable
recommendation.
Amend printed bill, page 27, strike lines 24 through 26.
Renumber succeeding subsection accordingly.
Page 28, before line 3 insert:
"(5) NOTWITHSTANDING ANY PROVISION OF THIS SECTION TO THE
CONTRARY, A CARRIER OR STATE AGENCY THAT IS REQUIRED PURSUANT TO
STATE OR FEDERAL LAW TO PURCHASE OR REIMBURSE A PAYER FOR A
PRESCRIPTION DRUG FOR WHICH THE BOARD HAS ESTABLISHED AN UPPER
PAYMENT LIMIT PURSUANT TO SECTION 10-16-1307 IS NOT SUBJECT TO AN
ENFORCEMENT ACTION FOR A VIOLATION OF SUBSECTION (1) OR (2) OF THIS
SECTION FOR THAT PARTICULAR PRESCRIPTION DRUG.".
Page 30, after line 20 insert:
"SECTION 4. Appropriation. (1) For the 2021-22 state fiscal year,
$680,711 is appropriated to the department of regulatory agencies. This
appropriation is from the division of insurance cash fund created in section
10-1-103 (3), C.R.S. To implement this act, the department may use this
appropriation as follows:
(a) $275,297 for use by the division of insurance for personal services,
which amount is based on an assumption that the division will require an
additional 3.0 FTE;
(b) $22,650 for use by the division of insurance for operating expenses;
and
(c) $382,824 for the purchase of legal services.
(2) For the 2021-22 state fiscal year, $382,824 is appropriated to the
department of law. This appropriation is from reappropriated funds received
from the department of regulatory agencies under subsection (1)(c) of this
section and is based on an assumption that the department of law will require
an additional 2.0 FTE. To implement this act, the department of law may use
this appropriation to provide legal services for the department of regulatory
agencies.".
Renumber succeeding sections accordingly.
Page 1, line 108, strike "AND".
Page 1, line 109, strike "VIOLATIONS." and substitute "VIOLATIONS; AND
MAKING AN APPROPRIATION."
Appro-
priations
Senate Journal, May 6
SB21-175 by Senator Jaquez Lewis and Gonzales; also Representative Caraveo and Kennedy--
Concerning the Colorado prescription drug affordability review board, and, in connection
therewith, directing the board to review the affordability of certain drugs and establish
upper payment limits for certain drugs; prohibiting certain entities from purchasing or
reimbursing for any drug for distribution in the state at an amount that exceeds the upper
payment limit established for the prescription drug; and establishing penalties for
violations.
Amendment No. 1, Health & Human Services Committee Amendment.
(Printed in Senate Journal, March 18, page(s) 285-287 and placed in members' bill files.)
Amendment No. 2, Appropriations Committee Amendment.
(Printed in Senate Journal, April 30, page 711 and placed in members' bill files.)
Amendment No. 3(L.044), by Senator Jaquez Lewis.
Amend printed bill, page 9, line 1, strike "DIVISION AS A TYPE 1 ENTITY." and
substitute "DIVISION.".
Page 23, line 24, strike "AS A TYPE 2 ENTITY".
Amendment No. 4(L.045), by Senator Jaquez Lewis.
Amend the Health and Human Services Committee Report, dated March 17,
2021, page 2, strike line 15 and substitute "HEALTH SERVICE ACT", PUB.L.
78-410;
(g) ORPHAN DRUG STATUS;".".
Amendment No. 5(L.046), by Senator Gonzales.
Amend printed bill, page 22, line 7, strike "AND".
Page 22, after line 7 insert:
"(c) THE STATUS OF THE PRESCRIPTION DRUG ON THE DRUG SHORTAGE
LIST PUBLISHED BY THE DRUG SHORTAGE PROGRAM WITHIN THE FDA; AND".
Reletter succeeding paragraph accordingly.
Amendment No. 6(L.047), by Senator Gonzales.
Amend printed bill, page 8, line 2, strike "10-16-1307 (5)." and substitute
"10-16-1307 (6).".
Page 22, after line 8 insert:
"(3) THE METHODOLOGY DETERMINED BY THE BOARD PURSUANT TO
SUBSECTION (2) OF THIS SECTION MUST CONSIDER THE IMPACT TO OLDER
ADULTS AND PERSONS WITH DISABILITIES AND SHALL NOT PLACE A LOWER
VALUE ON THEIR LIVES.".
Renumber succeeding subsections accordingly.
Amendment No. 7(L.048), by Senator Jaquez Lewis.
Amend printed bill, page 8, line 2, strike "10-16-1307 (5)." and substitute
"10-16-1307 (6).".
Page 22, after line 13 insert:
"(4) THE BOARD SHALL PROMULGATE RULES TO NOTIFY CONSUMERS OF
ANY DECISION TO ESTABLISH AN UPPER PAYMENT LIMIT PURSUANT TO THIS
SECTION.".
Renumber succeeding subsections accordingly.
Amendment No. 8(L.049), by Senator Gonzales.
Amend printed bill, page 23, line 11, strike "DECEMBER 31, 2021," and
substitute "MARCH 31, 2022,".
Amendment No. 9(L.050), by Senator Jaquez Lewis.
Amend printed bill, page 26, strike line 26 and substitute "CONSUMERS,
PRIORITIZING THE REDUCTION OF OUT-OF-POCKET COSTS FOR PRESCRIPTION
DRUGS.".
Amendment No. 10(L.052), by Senator Jaquez Lewis.
Amend the Health and Human Services Committee Report, dated March 17,
2021, page 3, strike line 22 and substitute "PROVIDERS, PHARMACIES, AND
PATIENTS' ABILITY TO ACCESS ANY PRESCRIPTION DRUGS FOR WHICH THE BOARD
HAS ESTABLISHED UPPER PAYMENT LIMITS;".".
Amendment No. 11(L.054), by Senator Gonzales.
Amend printed bill, page 8, after line 24 insert:
"(25) "WHOLESALER" HAS THE MEANING SET FORTH IN SECTION
12-280-103 (55).".
Page 23, line 26, strike "FOURTEEN" and substitute "FIFTEEN".
Page 24, line 4, strike "THIRTEEN" and substitute "FOURTEEN".
Page 24, line 23, strike "AND".
Page 24, line 24, strike "PHARMACISTS." and substitute "PHARMACISTS; AND".
Page 24, after line 24 insert:
"(M) ONE MEMBER REPRESENTING WHOLESALERS.".
Senate Journal, May 6
SB21-175 by Senator Jaquez Lewis and Gonzales; also Representative Caraveo and Kennedy--
Concerning the Colorado prescription drug affordability review board, and, in connection
therewith, directing the board to review the affordability of certain drugs and establish
upper payment limits for certain drugs; prohibiting certain entities from purchasing or
reimbursing for any drug for distribution in the state at an amount that exceeds the upper
payment limit established for the prescription drug; and establishing penalties for
violations.
Senator Ginal moved to amend the Report of the Committee of the Whole to show that the
following Ginal floor amendment, (L.090) to SB 21-175, did pass.
Amend printed bill, page 30, after line 9 insert:
"10-16-1315. Repeal of part. THIS PART 13 IS REPEALED, EFFECTIVE
SEPTEMBER 1, 2026. BEFORE THE REPEAL, THE FUNCTIONS OF THE BOARD ARE
SCHEDULED FOR REVIEW IN ACCORDANCE WITH SECTION 24-34-104.".
Renumber succeeding sections accordingly.
Page 30, after line 20, insert:
"SECTION 4. In Colorado Revised Statutes, 24-34-104, add
(27)(a)(XIII) as follows:
24-34-104. General assembly review of regulatory agencies and
functions for repeal, continuation, or reestablishment - legislative
declaration - repeal. (27) (a) The following agencies, functions, or both, are
scheduled for repeal on September 1, 2026:
(XVIII) THE COLORADO PRESCRIPTION DRUG AFFORDABILITY REVIEW
BOARD CREATED IN SECTION 10-16-1302.".
Renumber succeeding sections accordingly.
House Journal, May 25
21 SB21-175 be amended as follows, and as so amended, be referred to
22 the Committee of the Whole with favorable
23 recommendation:
24
25 Amend reengrossed bill, page 35, line 10, strike "$680,711" and
26 substitute "$730,711".
27
28 Page 35, line 14, strike "$275,297" and substitute "$325,297".
29
30
House Journal, June 3
35 Amendment recommended by Appropriations Report, dated May 25,
36 2021, and placed in member's bill file; Report also printed in House
37 Journal, May 25, 2021.
38
39 Laid Over until Friday, June 4, 2021.
House Journal, June 4
1 Amendment No. 1, Appropriations Report, dated May 25, 2021, and
2 placed in member's bill file; Report also printed in House Journal,
3 May 25, 2021.
4
5 Amendment No. 2, by Representative McKean.
6
7 Amend reengrossed bill, page 20, after line 11 insert:
8
9 "(h) INPUT FROM:
10 (I) PATIENTS AND CAREGIVERS AFFECTED BY THE CONDITION OR
11 DISEASE THAT IS TREATED BY THE PRESCRIPTION DRUG THAT IS UNDER
12 REVIEW BY THE BOARD; AND
13 (II) INDIVIDUALS WHO POSSESS SCIENTIFIC OR MEDICAL TRAINING
14 WITH RESPECT TO A CONDITION OR DISEASE TREATED BY THE
15 PRESCRIPTION DRUG THAT IS UNDER REVIEW BY THE BOARD;".
16
17 Reletter succeeding paragraphs accordingly.
18
19 Amendment No. 3, by Representative McKean.
20
21 Amend reengrossed bill, page 24, after line 19 insert:
22
23 "(10) FOR ANY UPPER PAYMENT LIMIT ESTABLISHED BY THE BOARD
24 PURSUANT TO THIS SECTION, THE BOARD SHALL:
25 (a) INQUIRE OF MANUFACTURERS OF THE PRESCRIPTION DRUG AS
26 TO WHETHER EACH SUCH MANUFACTURER IS ABLE TO MAKE THE
27 PRESCRIPTION DRUG AVAILABLE FOR SALE IN THE STATE AND REQUEST THE
28 RATIONALE FOR THE MANUFACTURER'S RESPONSE; AND
29 (b) SUBMIT ANNUALLY TO THE HEALTH AND HUMAN SERVICES
30 COMMITTEE OF THE SENATE AND THE HEALTH AND INSURANCE COMMITTEE
31 OF THE HOUSE OF REPRESENTATIVES, OR TO ANY SUCCESSOR COMMITTEES,
32 THE RESPONSE OF EACH MANUFACTURER TO THE INQUIRY DESCRIBED IN
33 SUBSECTION (10)(a) OF THIS SECTION.".
34
35 Amendment No. 4, by Representative Kennedy.
36
37 Amend reengrossed bill, page 18, lines 7 and 8, strike "THREE THOUSAND
38 DOLLARS" and substitute "TEN PERCENT".
39
40 Amendment No. 5, by Representative Kennedy
41
42 Amend reengrossed bill, page 23, line 11, strike "RETAIL".
43
44 Page 23, line 12, strike "A REASONABLE DISPENSING FEE." and substitute
45 "REASONABLE FEES,".
46
47 Amendment No. 6, by Representative Kennedy.
48
49 Amend reengrossed bill, page 4, strike lines 13 and 14 and substitute "and
50 protect Colorado residents and entities who purchase or reimburse for
51 prescription drugs from the excessive costs of prescription drugs,
52 including but not limited to state and local governments, contractors and
53 vendors, commercial health plans, providers, and pharmacies.".
54
55 As amended, ordered revised and placed on the Calendar for Third
56 Reading and Final Passage.
1 AMENDMENT(S) TO THE COMMITTEE OF THE WHOLE REPORT
2
3 Representative McKean moved to amend the Report of the Committee of
4 the Whole to show that L.134 the following McKean amendment to
House Journal, June 4
7 Amend reengrossed bill, page 34, strike lines 7 and 8 and substitute:
8
9 "10-16-1315. Exemptions. (1) NOTWITHSTANDING ANY
10 PROVISION OF THIS PART 13 TO THE".
11
12 Page 34, strike lines 11 and 12 and substitute "FOR, ANY PRESCRIPTION
13 DRUG THAT IS:
14 (a) DERIVED IN WHOLE OR IN PART FROM CANNABIS; OR
15 (b) USED TO TREAT CANCER OR THE SIDE EFFECTS OF CANCER.".
16
17 The amendment was declared lost by the following roll call vote:
18
19 YES 23 NO 39 EXCUSED 3 ABSENT
20 Amabile N Exum N Lynch Y Sirota N
21 Bacon N Froelich N McCluskie N Snyder N
22 Baisley Y Geitner Y McCormick N Soper Y
23 Benavidez N Gonzales-Gutierrez N McKean Y Sullivan N
24 Bernett N Gray N McLachlan N Tipper N
25 Bird N Hanks Y Michaelson Jenet N Titone N
26 Bockenfeld Y Herod E Mullica N Valdez A. N
27 Boesenecker N Holtorf Y Neville Y Valdez D. N
28 Bradfield Y Hooton N Ortiz N Van Beber Y
29 Caraveo N Jackson N Pelton Y Van Winkle Y
30 Carver Y Jodeh N Pico Y Weissman N
31 Catlin Y Kennedy N Ransom Y Will Y
32 Cutter N Kipp N Rich Y Williams Y
33 Daugherty N Larson Y Ricks N Woodrow N
34 Duran N Lontine E Roberts N Woog Y
35 Esgar N Luck E Sandridge Y Young N
36 Speaker N
House Journal, June 4
43 Amend printed bill, page 23, line 10, strike "AND".
44
45 Page 23, line 15, strike "LIMIT." and substitute "LIMIT; AND
46 (c) MUST REQUIRE THAT AN UPPER PAYMENT LIMIT ESTABLISHED
47 FOR ANY DRUG THAT IS AN ORPHAN DRUG OR OTHERWISE IDENTIFIED AS
48 FIRST-IN-CLASS MUST BE SUPPORTED BY:
49 (I) MEANINGFUL INPUT FROM PATIENTS AND CAREGIVERS
50 AFFECTED BY THE CONDITION OR DISEASE THAT IS TREATED BY THE
51 PRESCRIPTION DRUG, INCLUDING WITHOUT LIMITATION INPUT CONCERNING
52 CAREGIVER BURDEN, THE VALUE OF TREATING PATIENTS WITH UNMET
53 MEDICAL NEEDS, THE SEVERITY OF THE DISEASE OR CONDITION THAT IS
54 TREATED BY THE PRESCRIPTION DRUG, AND ANY OTHER
55 NON-HEALTH-RELATED ISSUES INCLUDING SOCIETAL IMPACT; AND
1 (II) MEANINGFUL INPUT FROM EXTERNAL EXPERTS ON THE
2 FOLLOWING TOPICS, WITHOUT LIMITATION:
3 (A) THE IMPACT OF PARTICULAR COVERAGE, COST SHARING,
4 TIERING, UTILIZATION MANAGEMENT, PRIOR AUTHORIZATION, MEDICATION
5 THERAPY MANAGEMENT, OR OTHER UTILIZATION MANAGEMENT POLICIES
6 ON ADHERENCE BY PATIENTS TO THE PRESCRIPTION DRUG AND ON ACCESS
7 TO THE PRESCRIPTION DRUG;
8 (B) THE DEMOGRAPHICS AND THE CLINICAL DESCRIPTION OF
9 PATIENT POPULATIONS TREATED BY THE DRUG; AND
10 (C) TO THE EXTENT THE DRUG IS AN ORPHAN DRUG APPROVED FOR
11 THE TREATMENT OF A RARE DISEASE, THE SEVERITY OF AND THE UNMET
12 MEDICAL NEED ASSOCIATED WITH THE RARE DISEASE, THE BENEFITS AND
13 RISKS OF THE DRUG AS A TREATMENT FOR THE RARE DISEASE, AND
14 FACTORS THAT MAY BE LIMITING ACCESS BY PATIENTS REQUIRING
15 TREATMENT FROM OR CONSULTATION WITH A RARE DISEASE SPECIALIST.
16 FOR THE PURPOSE OF THIS SUBSECTION (4)(c)(II), "EXTERNAL EXPERT"
17 MEANS AN INDIVIDUAL WHO POSSESSES SCIENTIFIC OR MEDICAL TRAINING
18 THAT THE BOARD LACKS WITH RESPECT TO A DISEASE TREATED BY A
19 PRESCRIPTION DRUG THAT IS UNDER REVIEW BY THE BOARD OR A RELATED
20 THERAPEUTIC AREA.".
21
22 The amendment was declared lost by the following roll call vote:
23
24 YES 23 NO 39 EXCUSED 3 ABSENT
25 Amabile N Exum N Lynch Y Sirota N
26 Bacon N Froelich N McCluskie N Snyder N
27 Baisley Y Geitner Y McCormick N Soper Y
28 Benavidez N Gonzales-Gutierrez N McKean Y Sullivan N
29 Bernett N Gray N McLachlan N Tipper N
30 Bird N Hanks Y Michaelson Jenet N Titone N
31 Bockenfeld Y Herod E Mullica N Valdez A. N
32 Boesenecker N Holtorf Y Neville Y Valdez D. N
33 Bradfield Y Hooton N Ortiz N Van Beber Y
34 Caraveo N Jackson N Pelton Y Van Winkle Y
35 Carver Y Jodeh N Pico Y Weissman N
36 Catlin Y Kennedy N Ransom Y Will Y
37 Cutter N Kipp N Rich Y Williams Y
38 Daugherty N Larson Y Ricks N Woodrow N
39 Duran N Lontine E Roberts N Woog Y
40 Esgar N Luck E Sandridge Y Young N
41 Speaker N
House Journal, June 4
48 Amend reengrossed bill, strike pages 22 and 23.
49
50 Page 24, strike lines 1 through 19.
51
52 Renumber succeeding C.R.S. sections accordingly.
53
54 The amendment was declared lost by the following roll call vote:
55
1 YES 24 NO 38 EXCUSED 3 ABSENT
2 Amabile N Exum Y Lynch Y Sirota N
3 Bacon N Froelich N McCluskie N Snyder N
4 Baisley Y Geitner Y McCormick N Soper Y
5 Benavidez N Gonzales-Gutierrez N McKean Y Sullivan N
6 Bernett N Gray N McLachlan N Tipper N
7 Bird N Hanks Y Michaelson Jenet N Titone N
8 Bockenfeld Y Herod E Mullica N Valdez A. N
9 Boesenecker N Holtorf Y Neville Y Valdez D. N
10 Bradfield Y Hooton N Ortiz N Van Beber Y
11 Caraveo N Jackson N Pelton Y Van Winkle Y
12 Carver Y Jodeh N Pico Y Weissman N
13 Catlin Y Kennedy N Ransom Y Will Y
14 Cutter N Kipp N Rich Y Williams Y
15 Daugherty N Larson Y Ricks N Woodrow N
16 Duran N Lontine E Roberts N Woog Y
17 Esgar N Luck E Sandridge Y Young N
18 Speaker N
House Journal, June 4
25 Amend reengrossed bill, page 23, line 16, after "(5)" insert "(a)".
26
27 Page 23, strike line 20 and substitute:
28 "ESTABLISHED; EXCEPT THAT AN UPPER PAYMENT LIMIT DOES NOT APPLY
29 TO A PRESCRIPTION DRUG THAT IS:
30 (I) ADMINISTERED IN A HOSPITAL INPATIENT OR OUTPATIENT
31 SETTING; AND
32 (II) PURCHASED FROM AN ENTITY LOCATED OUTSIDE COLORADO.".
33 (b) THE BOARD SHALL PROMULGATE RULES THAT ESTABLISH".
34
35 The amendment was declared lost by the following roll call vote:
36
37 YES 23 NO 39 EXCUSED 3 ABSENT
38 Amabile N Exum N Lynch Y Sirota N
39 Bacon N Froelich N McCluskie N Snyder N
40 Baisley Y Geitner Y McCormick N Soper Y
41 Benavidez N Gonzales-Gutierrez N McKean Y Sullivan N
42 Bernett N Gray N McLachlan N Tipper N
43 Bird N Hanks Y Michaelson Jenet N Titone N
44 Bockenfeld Y Herod E Mullica N Valdez A. N
45 Boesenecker N Holtorf Y Neville Y Valdez D. N
46 Bradfield Y Hooton N Ortiz N Van Beber Y
47 Caraveo N Jackson N Pelton Y Van Winkle Y
48 Carver Y Jodeh N Pico Y Weissman N
49 Catlin Y Kennedy N Ransom Y Will Y
50 Cutter N Kipp N Rich Y Williams Y
51 Daugherty N Larson Y Ricks N Woodrow N
52 Duran N Lontine E Roberts N Woog Y
53 Esgar N Luck E Sandridge Y Young N
54 Speaker N
55
1 Representative Pico moved to amend the Report of the Committee of the
261 2 Whole to show that L.029 the following Pico amendment to SB21-
3 did pass:
4
5 Amend reengrossed bill, page 7, line 27, strike "(1)(c)(II)(B),".
6
7 Page 8, line 1, after "(1.5);" insert "repeal (1)(c)(II)(B);".
8
9 Page 8, line 25, strike "and nuclear" and substitute "and nuclear".
10
11 Page 10, strike line 17 and substitute "rights-of-way.".
12
13 Page 10, strike lines 18 through 20.
14
15 The amendment was declared lost by the following roll call vote:
16
17 YES 23 NO 39 EXCUSED 3 ABSENT
18 Amabile N Exum N Lynch Y Sirota N
19 Bacon N Froelich N McCluskie N Snyder N
20 Baisley Y Geitner Y McCormick N Soper Y
21 Benavidez N Gonzales-Gutierrez N McKean Y Sullivan N
22 Bernett N Gray N McLachlan N Tipper N
23 Bird N Hanks Y Michaelson Jenet N Titone N
24 Bockenfeld Y Herod E Mullica N Valdez A. N
25 Boesenecker N Holtorf Y Neville Y Valdez D. Y
26 Bradfield Y Hooton N Ortiz N Van Beber Y
27 Caraveo N Jackson N Pelton Y Van Winkle Y
28 Carver Y Jodeh N Pico Y Weissman N
29 Catlin Y Kennedy N Ransom Y Will Y
30 Cutter N Kipp N Rich Y Williams Y
31 Daugherty N Larson N Ricks N Woodrow N
32 Duran N Lontine E Roberts N Woog Y
33 Esgar N Luck E Sandridge Y Young N
34 Speaker N